Ebit Değişiklik Tarih
Adma Biologics USD 62.75M 13.56M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Cytokinetics USD -178.37M 11.61M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.65B 71M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xoma USD -10.08M 4.4M 2024-06